Urolithiasis in the elderly

Canadian Journal of Urology

Volumn 18, Issue 3, 2011, Pages 5717-5720

  McCarthy, John Paul ^a   Skinner, Thomas A A ^a   Norman, Richard W ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Comorbidities; Geriatrics; Urolithiasis

Indexed keywords

AGE; AGED; ARTICLE; CASE CONTROL STUDY; COMORBIDITY; FEMALE; HUMAN; INCIDENCE; LITHOTRIPSY; MALE; MIDDLE AGED; PERCUTANEOUS NEPHROSTOMY; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; STENT; TREATMENT OUTCOME; UROLITHIASIS;

AGE FACTORS; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; LITHOTRIPSY; MALE; MIDDLE AGED; NEPHROSTOMY, PERCUTANEOUS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME; UROLITHIASIS;

EID: 80055070008     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lotan Y, Cadeddu JA, Roerhborn CG, Pak CY, Pearle MS. Cost-effectiveness of medical management strategies for nephrolithiasis. J Urol 2004;172(6 Pt 1):2275-2281.
2. Scales CD Jr, Curtis LH, Norris RD et al. Changing gender prevalence of stone disease. J Urol 2007;177(3):979-982.
3. Pak CY. Prevention and treatment of kidney stones. Role of medical prevention. J Urol 1989;141(3 Pt 2):798-801.
4. Johnson CM, Wilson DM, O'Fallon WM, Malek RS, Kurland LT. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int 1979;16(5):624-631.
5. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003;63(5):1817-1823.
6. Serio A, Fraioli A. Epidemiology of nephrolithiasis. Nephron 1999;81(Suppl 1):26-30.
7. Amato M, Lusini ML, Nelli F. Epidemiology of nephrolithiasis today. Urol Int 2004;72(Suppl 1):1-5.
8. Ljunghall S, Danielson BG. A prospective study of renal stone recurrences. Br J Urol 1984;56(2):122-124.
9. Williams RE. Long-term survey of 538 patients with upper urinary tract stone. Br J Urol 1963;35(12):416-437.
10. Trinchieri A, Ostini F, Nespoli R, Rovera F, Montanari E, Zanetti G. A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol 1999;162(1):27-30.
11. Ljunghall S, Hedstrand H. Epidemiology of renal stones in a middle-aged male population. Acta Med Scand 1975;197(6):439-445.
12. Gentle DL, Stoller ML, Bruce JR, Leslie SW. Geriatric urolithiasis. J Urol 1997;158(6):2221-2224.
13. Mhiri MN, Achiche S, Maazoun F, Bahloul A, Njeh M. Urinary calculi in a geriatric setting. Ann Urol (Paris) 1995;29(6-7):382-388.
14. Statistics Canada: 2006 Census: Portrait of the Canadian Population in 2006, by Age, and Sex. 2006;97-551-XWE2006001.
15. Pal SK, Katheria V, Hurria A. Evaluating the older patient with cancer: understanding frailty and the geriatric assessment. CA Cancer J Clin 2010;60(2):120-132.
16. Zilberman DE, Yong D, Albala DM. The impact of societal changes on patterns of urolithiasis. Curr Opin Urol 2010;20(2):148-153.
17. Thorleifsson G, Holm H, Edvardsson V et al. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet 2009;41(8):926-930.
18. Marickar YM, Salim A, Vijay A. Pattern of family history in stone patients. Urol Res 2009;37(6):331-335.
19. Edvardsson VO, Palsson R, Indridason OS, Thorvaldsson S, Stefansson K. Familiality of kidney stone disease in Iceland. Scand J Urol Nephrol 2009;43(5):420-424.
20. Koyuncu HH, Yencilek F, Eryildirim B, Sarica K. Family history in stone disease: how important is it for the onset of the disease and the incidence of recurrence? Urol Res 2010;38(2):105-109.
21. Pinkawa M, Fischedick K, Gagel B et al. Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment. BMC Cancer 2009;9:296.
22. Mao JJ, Armstrong K, Bowman MA, Xie SX, Kadakia R, Farrar JT. Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med 2007;20(5):434-443.
23. Abate N, Chandalia M, Cabo-Chan AV Jr et al. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 2004;65(2):386-392.
24. Porena M, Guiggi P, Micheli C. Prevention of stone disease. Urol Int 2007;79(Suppl 1):37-46.
25. Shlipak MG, Katz R, Kestenbaum B et al. Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C. Am J Nephrol 2009;30(3):171-178.
26. Kumar S, Sigmon D, Miller T et al. A new model of nephrolithiasis involving tubular dysfunction/injury. J Urol 1991;146(5):1384-1389.
27. Khan SR. Renal tubular damage/dysfunction: key to the formation of kidney stones. Urol Res 2006;34(2):86-91.
28. Khan SR, Canales BK. Genetic basis of renal cellular dysfunction and the formation of kidney stones. Urol Res 2009;37(4):169-180.
29. Patel SR, Haleblian GE, Pareek G. Percutaneous nephrolithotomy can be safely performed in the high-risk patient. Urology 2010;75(1):51-55.
30. Karami H, Mazloomfard MM, Golshan A, Rahjoo T, Javanmard B. Does age affect outcomes of percutaneous nephrolithotomy? J Urol 2010;7(1):17-21.